Biocryst Pharmaceuticals buy Cantor Fitzgerald
Start price
29.04.25
/
50%
€7.44
Target price
29.04.26
€17.56
Performance (%)
1.64%
End price
30.04.26
€7.56
Summary
This prediction ended on 30.04.26 with a price of €7.56. With a performance of 1.64%, the BUY prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals closed with a slight gain. Cantor_Fitzgerald has a follow-up prediction for Biocryst Pharmaceuticals where he still thinks Biocryst Pharmaceuticals is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biocryst Pharmaceuticals | 10.197% | 10.197% | 28.877% |
| iShares Core DAX® | 1,77 % | 3,45 % | 5,56 % |
| iShares Nasdaq 100 | -3,50 % | 1,61 % | 32,31 % |
| iShares Nikkei 225® | -4,94 % | 4,22 % | 57,83 % |
| iShares S&P 500 | 0,30 % | 2,58 % | 24,81 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $20.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
In the thread Trading Biocryst Pharmaceuticals
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€5.72
15.10.25
15.10.25
€22.38
15.10.26
15.10.26
68.53%
07.07.26
07.07.26
Stopped prediction by Cantor_Fitzgerald for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.79
30.06.26
30.06.26
€25.44
30.06.27
30.06.27
9.67%
07.07.26
07.07.26